Related Experiment Video
Updated: Mar 26, 2026
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased
Tetsuhide Ito1, Robert T Jensen2
1Department of Medicine & Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Abstract:
In multiple endocrine neoplasia type 1 (MEN1) patients, a number of recent studies compare the ability of different, new imaging modalities to existing modalities to localize the important neuroendocrine tumors (NETs) that contribute to their decreased life expectancy (pancreatic NETs [pNETs] and thymic carcinoids). These included the use of 68Ga-DOTATOC-PET/CT, endoscopic ultrasound and MRI. The current paper analyzes these results in light of current guidelines and controversies involved in the treatment/management of MEN1 patients. Particular attention is paid to results in these studies with thymic carcinoids and nonfunctional pNETs/gastrinomas, which recent studies show are particularly important in determining long-term survival. These studies show a number of promising imaging results but also raise a number of controversies, which will need to be addressed both in their use initially and for serial studies in these patients.
Insights
New imaging techniques like 68Ga-DOTATOC-PET/CT show promise for locating neuroendocrine tumors (NETs) in multiple endocrine neoplasia type 1 (MEN1) patients, aiding in management and improving survival rates.
Area of Science:
- Endocrinology
- Oncology
- Radiology
Background:
- Multiple Endocrine Neoplasia type 1 (MEN1) is a genetic disorder associated with increased risk of neuroendocrine tumors (NETs).
- Accurate localization of NETs, particularly pancreatic NETs (pNETs) and thymic carcinoids, is crucial for effective management and improving patient survival.
- Existing imaging modalities have limitations in detecting and characterizing these NETs.
Purpose of the Study:
- To analyze recent studies comparing novel imaging modalities with conventional methods for NET localization in MEN1 patients.
- To evaluate the efficacy of 68Ga-DOTATOC-PET/CT, endoscopic ultrasound, and MRI in identifying pNETs and thymic carcinoids.
- To discuss the implications of these findings in the context of current MEN1 management guidelines and controversies.
Main Methods:
- Systematic review and analysis of recent comparative studies on imaging modalities for MEN1-associated NETs.
- Focus on studies utilizing 68Ga-DOTATOC-PET/CT, endoscopic ultrasound, and MRI.
- Evaluation of imaging performance specifically for thymic carcinoids and nonfunctional pNETs/gastrinomas.
Main Results:
- Novel imaging techniques demonstrate promising results in localizing NETs in MEN1 patients.
- 68Ga-DOTATOC-PET/CT, endoscopic ultrasound, and MRI show potential for improved detection rates compared to older methods.
- Specific attention to thymic carcinoids and nonfunctional pNETs highlights their importance in long-term survival, with new imaging offering better characterization.
Conclusions:
- Recent advancements in imaging offer improved diagnostic capabilities for MEN1-associated neuroendocrine tumors.
- The findings suggest a potential shift in diagnostic strategies, but also highlight ongoing controversies in their application.
- Further research and guideline refinement are necessary to optimize the use of these advanced imaging modalities in the initial diagnosis and serial monitoring of MEN1 patients.
